This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Hanmi Pharmaceutical Co., Ltd.
Drug Names(s): mosapride/Bacillus subtilis/Streptococcas feacium
Description: HCP0613 is a fixed-dose combination of mosapride (Gasmotin), Bacillus subtilis, and Streptococcas feacium.
Additional information available to subscribers only: